Cover image for PDR guide to biological and chemical warfare response
Title:
PDR guide to biological and chemical warfare response
Author:
Sifton, David W.
Edition:
First edition.
Publication Information:
Montvale, NJ : Thomson/Physicians' Desk Reference, [2002]

©2002
Physical Description:
xii, 404 pages : illustrations ; 20 cm
Language:
English
Added Uniform Title:
Physicians' desk reference.
ISBN:
9781563634260
Format :
Book

Available:*

Library
Call Number
Material Type
Home Location
Status
Item Holds
Searching...
RA648 .P374 2002 Adult Non-Fiction Central Closed Stacks
Searching...

On Order

Summary

Summary

This fundamental reference can arm readers with the facts to cope with over 50 potential bioterrorism toxins, outlining the telltale signs and symptoms of each and summarizing the appropriate clinical response.


Reviews 2

Library Journal Review

Designed as a ready reference, the PDRR Guide highlights symptoms and effective treatments, including dosage and supportive care. The text is divided into seven sections: biological agents, chemical agents, treatment modalities, antibiotics, vaccines, medical safety, and government guidelines and advisories. Altogether, 50 biological and chemical agents, 50 treatment modalities, and 23 drugs are described in detail. Most of the toxicological data are extracted from MicromedexR, a series of four databases from Thomson offering advice drawn from medical literature, clinical specialists, and drug manufacturers. The information on prescribing antibiotics is in standard PDRR format. A directory of protective-clothing manufacturers and distributors is a nice addition. No index is provided, but there is a useful table of contents. Neither book includes color photos showing skin manifestations upon exposure to these agents, something that would be especially useful for clinicians unfamiliar with smallpox, anthrax, or other up-until-now exotic diseases. The Journal of the American Medical Association, for example, publishes consensus-based recommendations for the management of bioterrorist diseases that include such illustrations, and they can also be found in Sen. Bill Frist's recent, consumer-oriented When Every Moment Counts. While much of the information here is already available from disparate sources, these two volumes offer timesaving convenience at low cost with minimal overlap. If you must choose only one, take Bioterrorism and Public Health, as its index and easily readable table of contents facilitate subject searching. Anne C. Tomlin, Auburn Memorial Hosp. Lib., NY (c) Copyright 2010. Library Journals LLC, a wholly owned subsidiary of Media Source, Inc. No redistribution permitted.


Choice Review

The anthrax experience in the fall of 2001 caught many health professionals off guard. How would they respond to a biological or chemical attack? As an adjunct to the venerable PDR, this handy volume provides health professionals with a quick and easy-to-use reference guide to such threats. The work is divided into seven sections, beginning with overviews of biological agents and chemical agents, followed by treatment modalities, antibiotic prescribing information, vaccine information, medical safety, and government guidelines and advisories. The compilation is concise, presenting only the essential facts regarding incubation, progression, prognosis, supportive care, dosing information, precautionary measures, and effective antibiotics and vaccines. Much of the information has been peer-reviewed by clinical experts and reproduced from current drug databases. A convenient and practical guide to responding to biological and chemical warfare, this volume is recommended as an authoritative resource for health care professionals. J. D. Campbell University of Missouri--Columbia


Table of Contents

Forewordp. vii
How to Use This Bookp. ix
Section 1 Biological Agents
Aflatoxinsp. 3
Anthraxp. 3
Botulismp. 5
Brucellosisp. 7
Crimean-Congo Hemorrhagic Feverp. 9
Ebola and Marburg Filovirusesp. 11
E. Coli 0157:H7p. 12
Glandersp. 14
Hantavirus Pulmonary Syndromep. 16
Junin (Argentine Hemorrhagic Fever)p. 17
Lassa Feverp. 19
Paralytic Shellfish Toxinsp. 21
Plaguep. 22
Q Feverp. 23
Ricin (Toxalbumins)p. 25
Rocky Mountain Spotted Feverp. 27
Shigellap. 28
Smallpoxp. 30
Staphylococcusp. 32
Tetrodotoxinp. 33
Trichothecene Mycotoxinsp. 35
Tularemiap. 36
Typhusp. 38
Venezuelan Equine Encephalitisp. 40
Section 2 Chemical Agents
Adamsitep. 45
Arsinep. 46
Chlorinep. 48
Chloropicrinp. 49
CNp. 50
CRp. 52
CSp. 53
Cyanidep. 55
Cyanogenp. 56
Cyanogen Bromidep. 58
Cyanogen Chloridep. 59
Cyanogen Iodidep. 60
Diphenylchloroarsinep. 62
Diphosgenep. 63
Hydrogen Cyanidep. 65
Lewisitep. 66
LSDp. 68
Mustard Gasp. 69
Nitrogen Mustardp. 71
Nuclear Radiationp. 72
Phosgenep. 74
Phosgene Oximep. 76
Quinuclidinyl Benzilate (BZ)p. 77
Sarinp. 79
Somanp. 81
Tabunp. 82
VXp. 84
Section 3 Treatment Modalities in an Attack
Activated Charcoalp. 89
Albuterolp. 89
Aminophyllinep. 90
Amoxicillinp. 91
Amyl Nitritep. 92
Anthrax Vaccine, Adsorbedp. 93
Atropinep. 94
Botulinum Antitoxinp. 94
Chloramphenicolp. 96
Ciprofloxacinp. 97
Dexamethasonep. 100
Diazepamp. 101
Dimercaprolp. 102
Dopamine Hydrochloridep. 103
Doxycyclinep. 104
Erythromycinp. 107
Erythromycin Lactobionatep. 108
Filgrastimp. 109
Fluorometholonep. 110
Gentamicin Sulfatep. 110
Hydrocortisonep. 112
5-Hydroxytryptophan (5-HTP)p. 112
Levofloxacinp. 113
Lidocainep. 114
Lorazepamp. 115
Magnesium Sulfatep. 116
Methylprednisolonep. 117
Metoclopramide Hydrochloridep. 119
Norepinephrine Bitartratep. 119
Ofloxacinp. 120
Penicillin G Potassiump. 121
Penicillin V Potassiump. 122
Permethrinp. 123
Phenytoinp. 123
Polyethylene Glycolp. 126
Pralidoxime Chloridep. 126
Prednisonep. 127
Promethazine Hydrochloridep. 129
Pyridostigmine Bromidep. 130
Rifampinp. 131
Sargramostimp. 133
Smallpox Vaccinep. 133
Sodium Bicarbonatep. 134
Sodium Nitritep. 135
Sodium Phosphatep. 136
Sodium Sulfatep. 136
Sodium Thiosulfatep. 136
Streptomycin Sulfatep. 137
Succimer (DMSA)p. 138
Sulfamethoxazole/ Trimethoprimp. 139
Terbutalinep. 141
Tetracyclinep. 142
Section 4 Antibiotic Prescribing Information
Achromycin V Capsulesp. 147
Amoxil Capsules, Chewable Tablets, Powder for Oral Suspension, and Tabletsp. 150
Augmentin Powder for Oral Suspension and Chewable Tabletsp. 160
Augmentin Tabletsp. 169
Bactrim DS Tablets Tablets/Pediatric Suspensionp. 177
Cipro IVp. 185
Cipro IV Bulk Packagep. 199
Cipro Tablets and Oral Suspensionp. 213
Declomycin Tabletsp. 228
E.E.S. Granules, 200 Liquid, 400 Filmtab Tablets, and 400 Liquidp. 232
Erythromycin Base Filmtab Tabletsp. 238
Floxin IVp. 243
Floxin Tabletsp. 255
Levaquin Tablets/Injectionp. 267
Minocin IVp. 285
Minocin Pellet-Filled Capsulesp. 289
Minocin Oral Suspensionp. 295
Pfizerpen for Injectionp. 299
Rifadin Capsules/Rifadin IVp. 304
Streptomycin Sulfate Injection (Pfizer)p. 313
Vibramycin Hyclate Intravenousp. 318
Vibramycin Syrup, Capsules, Oral Suspension, and Vibra-Tabsp. 322
Section 5 Vaccine Information
Anthrax Vaccinep. 331
Smallpox Vaccinep. 340
Section 6 Medical Safety
Precautionary Measures During Bioterror Attackp. 361
Interim Recommendations for the Selection and Use of Protective Clothing and Respirators Against Biological Agentsp. 364
Directory of Protective Clothing Suppliersp. 367
Section 7 Government Guidelines and Advisories
Interim Guidelines for Investigation of and Response to Bacillus Anthracis Exposuresp. 375
Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthraxp. 379
Updated Recommendations for Antimicrobial Prophylaxis Among Asymptomatic Pregnant Women After Exposure to Bacillus Anthracisp. 384
Update: Interim Recommendations for Antimicrobial Prophylaxis for Children and Breastfeeding Mothers and Treatment of Children with Anthraxp. 386
Children and Anthrax: A Fact Sheet for Cliniciansp. 390
Statement by The Department of Health and Human Services Regarding Additional Options for Preventive Treatment for Those Exposed to Inhalational Anthraxp. 395
Smallpox Vaccine for Bioterrorism Preparedness: Excerpt from the Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001p. 398